Monoclonal antibody or antigen-binding fragment thereof that binds specifically to bcma, and use thereof

Abstract

The present invention relates to the fields of biotechnology and medicine, particularly to a monoclonal antibody or antigen-binding fragment thereof that binds specifically to BCMA. The invention further relates to nucleic acids encoding said antibody, expression vectors, host cells and methods for producing them, methods for producing the antibodies according to the invention, pharmaceutical compositions comprising the antibody according to the invention, pharmaceutical compositions comprising the antibody according to the invention and other therapeutically active compounds, methods for treating BCMA-mediated diseases or disorders, uses of the antibodies or pharmaceutical compositions thereof for treating BCMA-mediated diseases or disorders, and uses of the antibodies and other therapeutically active compounds for treating BCMA-mediated diseases or disorders.